Skip to content

OptimizeRx OPRX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin70%+2.8pp67.3%+1.9pp65.3%+0.9pp64.4%+8.5pp55.9%+15.6pp
Net margin6.4%+1.7pp4.7%+4.7pp0%+9.5pp-9.4%+10.7pp-20.1%+16.6pp
Returns
Return on equity5.6%+1.4pp4.2%+4.2pp0%+8.2pp-8.2%+4.7pp-12.9%+3.6pp
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.7×0.0×0.6×+0.2×0.4×+0.1×
Liquidity
Current ratio5.4×+2.3×0.0×+0.5×2.6×-0.2×2.8×-0.1×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.3×0.0×
Per Share
Book value per share$6.91+2.3%$6.75+7.5%$6.28+0.2%$6.27-0.3%$6.29-1.6%
Valuation
Market capitalization$107.34M-54.1%$228.53M-40.0%$380.58M+59.5%$238.59M+49.0%$160.13M+78.9%
Price / sales-1.2×2.1×-1.4×3.5×+1.2×2.3×+0.2×2.1×+0.5×
Price / book0.8×-1.1×1.8×-1.3×3.1×+1.1×+0.6×1.4×+0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are OptimizeRx's profit margins?
OptimizeRx (OPRX) runs a 70.0% gross margin and a 13.2% operating margin, with a 6.4% net margin.
Where do OptimizeRx's ratios come from?
Every ratio is computed from OptimizeRx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.